All Posts: health disparities
-
Computer Models Fill Critical Knowledge Gaps To Help Reduce Cancer Disparities
Reducing health disparities in incidence and mortality for major types of cancers can be aided by sophisticated computer modeling efforts, according to a new, wide-ranging perspective by researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues. A collection of new studies in the November 8, 2023, special issue of JNCI devoted to cancer disparities modeling outlines a path forward.
Category: News Release
-
Research To Help Patients Make Informed Decisions About Breast MRI
While many people think that breast cancer screening and mammography are synonymous, Claire Conley, PhD, wants people to know that women who are at higher than average risk for breast cancer may also receive a breast MRI.
Category: Lombardi Stories
-
Ralph Lauren Center for Cancer Prevention — Part of Washington’s Fabric
Lombardi Comprehensive Cancer Center’s newly dedicated Ralph Lauren Center for Cancer Prevention, with its quadrupling of health-focused staff, brings renewed hope that those who have been historically underserved in the Washington, DC, area will now have access to more cancer-related services and the potential of turning the tide on the high rate of cancer in the city.
Category: Lombardi Stories
-
Georgetown Announces New Ralph Lauren Center for Cancer Prevention To Address Health Disparities in Washington, D.C.
Media Contact Karen Teberkm463@georgetown.edu WASHINGTON (April 10, 2023) — The Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center will open on Mond
Category: News Release
-
Starting Mammography at Age 40 Would Reduce Disparities in Deaths for Black Women
WASHINGTON (October 18, 2021) — If Black women begin mammography screening every other year starting at age 40, breast cancer deaths could be reduced by 57 percent compared to starting screening 10 years later, according to analyses conducted by a modeling team that is part of the Cancer Intervention and Surveillance Modeling Network (CISNET), funded […]
Category: News Release
-
Adams-Campbell Selected for Top Award in Preventive Oncology
(March 28, 2021) — Lucile Adams-Campbell, PhD, professor of oncology and associate director for minority health and health disparities research at Georgetown Lombardi Comprehensive Cancer Center, will receive the Joseph F. Fraumeni, Jr., Distinguished Achievement Award from the American Society of Preventive Oncology. The honor will be bestowed virtually on March 29 at the organization’s […]
Category: Special Stories
-
Lombardi at 50: Community Outreach to Reduce Health Disparities
(March 5, 2020) — When Georgetown Lombardi Comprehensive Cancer Center’s Office of Minority Health and Health Disparities Research was created in 2008, its associate director, Lucile Adams-Campbell, PhD — the nation’s first black female epidemiologist — had a clear vision of need about the work ahead within the community. “Georgetown can come to everyone but […]
Category: Lombardi Stories
-
Palbociclib is Safe for Women with Advanced Breast Cancer Who Have Unique Gene Alteration
WASHINGTON (December 11, 2019) — Women who receive palbociclib (Ibrance®) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN) can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi […]
Category: News Release
-
Tipo Agressivo de Câncer de Mama é Influenciado pela Ação Conjunta de Genes e RNA
Mulheres Latinas são frequentemente diagnosticadas em estágios avançados de câncer de mama do tipo triplo-negativo e podem se beneficiar de tratamentos que tem como alvo a biologia de seus tumores. WASHINGTON (22 de outubro de 2019) — Mulheres diagnosticadas com um tipo menos comum e agressivo de câncer de mama, conhecido como triplo-negativo, podem ser diferenciadas […]
Category: News Release
-
Aggressive Form of Breast Cancer Influenced by Dual Action of Genes and RNA
Latina women are typically diagnosed with aggressive triple-negative breast cancer at late stages and could benefit from treatments targeted to the biology of their disease. Media Contact: Kar
Category: News Release